Amyloid Beta-directed Antibody Interactions [MoA] - N0000193950

Pharmacologic Class Information

Pharmacologic Code N0000193950
Pharmacologic Name Amyloid Beta-directed Antibody Interactions
Pharmacologic Uses
  • amyloid beta-directed antibody
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Amyloid Beta-directed Antibody Interactions

The following table contains 2 products whose active ingredient are classified under the same pharmacologic class Amyloid Beta-directed Antibody Interactions [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
64406-101Aduhelm Non-Proprietary Name: AducanumabInjection, SolutionIntravenousBiogen Inc.ACTIVE
64406-102Aduhelm Non-Proprietary Name: AducanumabInjection, SolutionIntravenousBiogen Inc.ACTIVE